Gut microbiota-derived products activate hepatic TLR4, which has been implicated in the development of alcoholic steatohepatitis, NASH, liver fibrosis and hepatocellular carcinoma [6]. The gene discussed is TLR4; the disease is metabolic dysfunction-associated steatohepatitis.